Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Fidelity cuts Google stake by nearly a third amid shift to cheaper searches

Published 03/02/2015, 10:56 AM
Updated 03/02/2015, 10:56 AM
© Reuters. People pose with laptops in front of projection of Google logo in this picture illustration taken in Zenica

(Reuters) - One of Google Inc (NASDAQ:GOOGL)'s largest investors has cut its exposure to the company by nearly a third over the past several months amid worries about a shift to cheaper searches on mobile phones.

The $107 billion Fidelity Contrafund cut its stake in Google to 5.2 percent of net assets as of Jan. 31, from 7.3 percent of net assets as of June 30.

"The firm continued to do phenomenally innovative things, but it is fighting a shift away from desktop search to less-expensive searches on mobile phones," Fidelity Investments portfolio manager Will Danoff said in Contrafund's annual report, released on Feb. 28th.

Danoff is considered one of the best stock pickers in the mutual fund industry, with Contrafund producing an average annual total return of 9.9 percent over the past 10 years. That's nearly 2 percentage points better than the benchmark S&P 500's average annual return of 7.99 percent during the same period, according to Morningstar Inc.

Still, in 2014, Google weighed down Contrafund's performance, along with a number of other large-cap funds with big positions in the stock. Danoff turned in one of his most disappointing performances of the past decade as Contrafund's 2014 total return of 9.56 percent lagged the S&P 500's 13.69 percent advance.

"In the strong-performing health care sector, I could have done a much better job with surging biotechnology stocks," Danoff said in the annual report for investors. "Notable mistakes included not owning enough Amgen (NASDAQ:AMGN), a biotech firm that made excellent advances, and avoiding index stock Allergan (NYSE:AGN), the specialty drug company that announced plans to be acquired by Actavis (NYSE:ACT)."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.